Suppr超能文献

单克隆抗体PG-B6a和PG-B6p分别识别位于人BCL-6蛋白氨基末端区域的一个高度保守表位和一个抗甲醛表位。

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.

作者信息

Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye B H, Gambacorta M, Pacini R, Baroni C D, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martelli M F, Pelicci P G, Dalla-Favera R, Falini B

机构信息

Institute of Hematology, University of Perugia, Italy.

出版信息

Am J Pathol. 1996 May;148(5):1543-55.

Abstract

The human BCL-6 gene, which is rearranged in approximately 30% of diffuse large B cell lymphomas, encodes a 706-amino-acid nuclear protein of the Kruppel-type zinc finger transcription factors mainly expressed in normal germinal center B cells and related lymphomas. Four monoclonal antibodies (PG-B6, PG-B6a, PG-B6p, and PG-B6m), specifically directed against the human BCL-6 protein, were generated by immunizing BALB/c mice with a recombinant protein corresponding to the BCL-6 amino-terminal region (amino acids 3 to 484). The PG-B6 monoclonal antibody reacted with a BCL-6 epitope sensitive to fixatives and preserved in all mammalian species. PG-B6a (a is for avian) recognized the most evolutionarily conserved BCL-6 epitope (expressed in all animal species including avian). PG-B6p (p is for paraffin) recognized a fixative-resistant epitope of BCL-6 that was detectable on paraffin sections after microwave heating in 1 mmol/L EDTA buffer. PG-B6m (m is for mantle) was the least specific monoclonal antibody as, in addition to BCL-6, it reacted with a yet undefined antigen selectively located in the cytoplasm of mantle and marginal zone B cells. All monoclonal antibodies detected strong nuclear expression of BCL-6 in follicular lymphomas, diffuse large B cell lymphomas, Burkitt's lymphomas, and nodular, lymphocyte-predominance Hodgkin's disease. In diffuse large B cell lymphomas, BCL-6 expression was independent of BCL-6 gene rearrangements and did not correlate with expression of other markers or the proliferation index. BCL-6 was not expressed in B-CLL, hairy cell leukemia, mantle-cell- and marginal-zone-derived lymphomas. Labeling of paraffin sections with PG-B6p proved useful for differentiating proliferation centers in B-CLL (BCl-2+/BCL-6-) from trapped germinal centers in mantle cell lymphomas (BCL-2-/BCL-6+) and for identifying neoplastic cells in cases of nodular, lymphocyte-predominance Hodgkin's disease. Because of their high specificity, wide reactivity in humans and animal species including avians (PG-B6a), and suitability for labeling routine paraffin sections (PG-B6p), the reagents described in this paper should prove valuable in both research and diagnostics.

摘要

人类BCL-6基因在约30%的弥漫性大B细胞淋巴瘤中发生重排,该基因编码一种含706个氨基酸的核蛋白,属于Kruppel型锌指转录因子,主要在正常生发中心B细胞及相关淋巴瘤中表达。通过用对应于BCL-6氨基末端区域(氨基酸3至484)的重组蛋白免疫BALB/c小鼠,产生了四种特异性针对人类BCL-6蛋白的单克隆抗体(PG-B6、PG-B6a、PG-B6p和PG-B6m)。PG-B6单克隆抗体与对固定剂敏感且在所有哺乳动物物种中均能保留的BCL-6表位发生反应。PG-B6a(a代表禽类)识别出进化上最保守的BCL-6表位(在包括禽类在内的所有动物物种中均有表达)。PG-B6p(p代表石蜡)识别出BCL-6的一个抗固定剂表位,该表位在1 mmol/L EDTA缓冲液中经微波加热后在石蜡切片上可检测到。PG-B6m(m代表套细胞)是特异性最低的单克隆抗体,因为除了BCL-6外,它还与一种选择性位于套细胞和边缘区B细胞胞质中的未明确抗原发生反应。所有单克隆抗体均在滤泡性淋巴瘤、弥漫性大B细胞淋巴瘤、伯基特淋巴瘤及结节性淋巴细胞为主型霍奇金病中检测到BCL-6的强核表达。在弥漫性大B细胞淋巴瘤中,BCL-6表达独立于BCL-6基因重排,且与其他标志物的表达或增殖指数无关。BCL-6在B细胞慢性淋巴细胞白血病、毛细胞白血病、套细胞和边缘区来源的淋巴瘤中不表达。用PG-B6p标记石蜡切片有助于区分B细胞慢性淋巴细胞白血病中的增殖中心(BCl-2+/BCL-6-)与套细胞淋巴瘤中的陷入生发中心(BCL-2-/BCL-6+),并有助于识别结节性淋巴细胞为主型霍奇金病病例中的肿瘤细胞。由于本文所述试剂具有高特异性、在包括禽类在内的人类和动物物种中具有广泛反应性(PG-B6a)以及适用于标记常规石蜡切片(PG-B6p),它们在研究和诊断中都应具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef52/1861546/1a7a7e485648/amjpathol00041-0219-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验